Skip to main content
. Author manuscript; available in PMC: 2012 Jun 13.
Published in final edited form as: Int J Sport Nutr Exerc Metab. 2011 Apr;21(2):146–154. doi: 10.1123/ijsnem.21.2.146

Table 2.

Individual Adverse Reactions With Oral Ingestion of N-Acetylcysteine Solution

Adverse reaction Dose
0 mg/kg 35 mg/kg 70 mg/kg 140 mg/kg
Gastrointestinal
 upset stomach H1, I1 F1, H1, I2 A1, C1, D2, E1, I1, J1
 nausea C1, H1, J1
 stomach or intestinal gas F1, H1 E1, F1 F1, I3 A1, C2, D2, F2, I2, J1
Nongastrointestinal
 sleepiness A1, D1, H1 D1 B1, C1, D1 F1, I1
 metallic taste J2 A1 A1, D1, I1 A1, H1, I1, J1
 light-headedness H1 D1 J1
 redness of eye, face, or hands F1
 cough D1

Note. Uppercase letters (A–J) refer to individual subjects from Arm 2. Superscripts show ranked intensity of adverse reactions reported by each subject. Ranked intensities are (1) mild, (2) moderate, and (3) severe. Subjects who indicated “none” (0) for an adverse reaction are omitted for clarity. None of the subjects experienced welts or wheezing. See Table 1 for further details.